Cargando…
Good response to neoadjuvant chemoradiotherapy predicts good oncological outcome in locally advanced rectal cancer
BACKGROUND: After pre-operative concurrent long course chemoradiotherapy (CRT), pathologic complete response (pCR) has been reported with better oncologic outcomes in many articles, whether a moderate response (TRG1) can translate into good clinical outcome remains uncertain. METHODS: A total of 132...
Autores principales: | Zhang, Chi, Xu, Liping, Qin, Qin, Liu, Jia, Tang, Xinyu, Jiang, Nan, Zhang, Zhaoyue, Li, Fei, Cheng, Hongyan, Chen, Jiayan, Sun, Xinchen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799075/ https://www.ncbi.nlm.nih.gov/pubmed/35116744 http://dx.doi.org/10.21037/tcr.2019.01.17 |
Ejemplares similares
-
Neoadjuvant chemoradiotherapy with capecitabine based regimen in locally advanced rectal cancer: A retrospective study
por: Li, Fei, et al.
Publicado: (2023) -
Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2018) -
A nomogram for predicting good response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a retrospective, double-center, cohort study
por: Wang, Guancong, et al.
Publicado: (2022) -
Assessment of T and N staging with MRI(3)T in lower and middle rectal cancer and impact on clinical strategy
por: Xu, Liping, et al.
Publicado: (2020) -
Neoadjuvant therapy of metformin is associated with good tumor response after preoperative concurrent chemoradiotherapy for rectal cancer
por: Han, Jeonghee, et al.
Publicado: (2022)